HomeRX • CVE
add
Biosyent Inc
Previous close
$15.50
Day range
$15.25 - $15.44
Year range
$9.20 - $15.80
Market cap
179.74M CAD
Avg Volume
5.76K
P/E ratio
20.52
Dividend yield
1.43%
Primary exchange
CVE
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 9.67M | 9.95% |
Operating expense | 5.22M | 10.62% |
Net income | 1.99M | 23.47% |
Net profit margin | 20.59 | 12.27% |
Earnings per share | — | — |
EBITDA | 2.57M | -2.00% |
Effective tax rate | 19.63% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.65M | 79.74% |
Total assets | 49.44M | 19.54% |
Total liabilities | 7.97M | 25.45% |
Total equity | 41.47M | — |
Shares outstanding | 11.26M | — |
Price to book | 4.21 | — |
Return on assets | 11.44% | — |
Return on capital | 13.39% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 1.99M | 23.47% |
Cash from operations | 3.49M | 33.23% |
Cash from investing | 2.39M | 170.70% |
Cash from financing | -638.78K | 84.79% |
Net change in cash | 5.23M | 882.26% |
Free cash flow | 2.19M | -4.39% |
About
Founded
1947
Headquarters
Website
